- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Lupin Limited — Updates, 04-09-2026: Press Release
04-09-2026 | 05:38 pm
04-09-2026 | 05:38 pm
Lupin received U.S. FDA approval for Modafinil Tablets (100 mg & 200 mg) to treat excessive sleepiness. This key business development targets a market with estimated annual U.S. sales of USD 7.07 Cr.
No comments yet. Be the first to comment!